Suven Life Sciences Limited (SUVEN) Share Price & AI Investment Analysis

Suven Life Sciences Limited, a clinical-stage biopharmaceutical company, develops novel therapeutics for central nervous system disorders and unmet needs in mental health in India, the United States, Europe, and internationally. It engages in the development of Masupirdine (SUVN-502), a 5-HT6 receptor antagonist for the treatment of cognitive and neuropsychiatric symptoms of Alzheimer's disease; and Samelisant (SUVN-G3031), a histamine H3 receptor inverse agonist/antagonist for the treatment of narcolepsy with or without cataplexy and idiopathic hypersomnia. The company also develops Ropanican. Track Suven Life Sciences Limited's live NSE:SUVEN share price ₹337.90 (-1.07%), market cap ₹₹95B. MarketRipple's AI analysis covers the investment thesis, ripple-chain impact, and Healthcare sector outlook for SUVEN — real-time NSE India stock intelligence.